Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...
Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...
Certolizumab pegol in combination with methotrexate or as a monotherapy improves clinical and functional outcomes in patients with active rheumatoid arthritis with an inadequate response to ...